197 related articles for article (PubMed ID: 33757387)
1. Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds.
Rahman F; Nguyen TM; Adekoya OA; Campestre C; Tortorella P; Sylte I; Winberg JO
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):819-830. PubMed ID: 33757387
[TBL] [Abstract][Full Text] [Related]
2. The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.
Sylte I; Dawadi R; Malla N; von Hofsten S; Nguyen TM; Solli AI; Berg E; Adekoya OA; Svineng G; Winberg JO
PLoS One; 2018; 13(8):e0200237. PubMed ID: 30075004
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of pseudolysin and thermolysin by hydroxamate-based MMP inhibitors.
Adekoya OA; Sjøli S; Wuxiuer Y; Bilto I; Marques SM; Santos MA; Nuti E; Cercignani G; Rossello A; Winberg JO; Sylte I
Eur J Med Chem; 2015 Jan; 89():340-8. PubMed ID: 25462250
[TBL] [Abstract][Full Text] [Related]
4. Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases.
Rahman F; Wushur I; Malla N; Åstrand OAH; Rongved P; Winberg JO; Sylte I
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011288
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.
Sjøli S; Nuti E; Camodeca C; Bilto I; Rossello A; Winberg JO; Sylte I; Adekoya OA
Eur J Med Chem; 2016 Jan; 108():141-153. PubMed ID: 26638045
[TBL] [Abstract][Full Text] [Related]
6. Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity.
Tauro M; Laghezza A; Loiodice F; Piemontese L; Caradonna A; Capelli D; Montanari R; Pochetti G; Di Pizio A; Agamennone M; Campestre C; Tortorella P
J Enzyme Inhib Med Chem; 2016; 31(sup4):25-37. PubMed ID: 27556138
[TBL] [Abstract][Full Text] [Related]
7. Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.
Santamaria S; Nuti E; Cercignani G; La Regina G; Silvestri R; Supuran CT; Rossello A
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):947-54. PubMed ID: 25694065
[TBL] [Abstract][Full Text] [Related]
8. Specific interactions between zinc metalloproteinase and its inhibitors: Ab initio fragment molecular orbital calculations.
Ara A; Kadoya R; Ishimura H; Shimamura K; Sylte I; Kurita N
J Mol Graph Model; 2017 Aug; 75():277-286. PubMed ID: 28618335
[TBL] [Abstract][Full Text] [Related]
9. Proposal of selective inhibitor for bacterial zinc metalloprotease: Molecular mechanics and ab initio molecular orbital calculations.
Imai K; Saito R; Ezawa T; Sugiyama S; Sylte I; Kurita N
J Mol Graph Model; 2022 Jan; 110():108047. PubMed ID: 34655919
[TBL] [Abstract][Full Text] [Related]
10. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors.
Laghezza A; Luisi G; Caradonna A; Di Pizio A; Piemontese L; Loiodice F; Agamennone M; Tortorella P
Bioorg Med Chem; 2020 Feb; 28(3):115257. PubMed ID: 31874775
[TBL] [Abstract][Full Text] [Related]
12. Dipeptide inhibitors of thermolysin and angiotensin I-converting enzyme.
Khan MT; Dedachi K; Matsui T; Kurita N; Borgatti M; Gambari R; Sylte I
Curr Top Med Chem; 2012; 12(16):1748-62. PubMed ID: 23030610
[TBL] [Abstract][Full Text] [Related]
13. Tackling Pseudomonas aeruginosa Virulence by a Hydroxamic Acid-Based LasB Inhibitor.
Kany AM; Sikandar A; Yahiaoui S; Haupenthal J; Walter I; Empting M; Köhnke J; Hartmann RW
ACS Chem Biol; 2018 Sep; 13(9):2449-2455. PubMed ID: 30088919
[TBL] [Abstract][Full Text] [Related]
14. Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.
Hanessian S; Bouzbouz S; Boudon A; Tucker GC; Peyroulan D
Bioorg Med Chem Lett; 1999 Jun; 9(12):1691-6. PubMed ID: 10397503
[TBL] [Abstract][Full Text] [Related]
15. Virtual Screening on MMP-13 Led to Discovering New Inhibitors Including a Non-Zinc Binding and a Micro Molar One: A Successful Example of Receptor Selection According to Cross-Docking Results for a Flexible Enzyme.
Ramezani M; Shamsara J
Comb Chem High Throughput Screen; 2017; 20(8):719-725. PubMed ID: 28814230
[TBL] [Abstract][Full Text] [Related]
16. New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors.
Beutel B; Song J; Konken CP; Korpos E; Schinor B; Gerwien H; Vidyadharan R; Burmeister M; Li L; Haufe G; Sorokin L
Bioconjug Chem; 2018 Nov; 29(11):3715-3725. PubMed ID: 30277751
[TBL] [Abstract][Full Text] [Related]
17. Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.
Xie XW; Wan RZ; Liu ZP
ChemMedChem; 2017 Aug; 12(15):1157-1168. PubMed ID: 28722301
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the binding specificity of two bacterial metalloproteases, LasB of Pseudomonas aeruginosa and ZapA of Proteus mirabilis, using N-alpha mercaptoamide template-based inhibitor analogues.
Carson L; Cathcart GR; Ceri H; Walker B; Gilmore BF
Biochem Biophys Res Commun; 2012 Jun; 422(2):316-20. PubMed ID: 22575503
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.
Reiter LA; Rizzi JP; Pandit J; Lasut MJ; McGahee SM; Parikh VD; Blake JF; Danley DE; Laird ER; Lopez-Anaya A; Lopresti-Morrow LL; Mansour MN; Martinelli GJ; Mitchell PG; Owens BS; Pauly TA; Reeves LM; Schulte GK; Yocum SA
Bioorg Med Chem Lett; 1999 Jan; 9(2):127-32. PubMed ID: 10021913
[TBL] [Abstract][Full Text] [Related]
20. Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview.
Adhikari N; Mukherjee A; Saha A; Jha T
Eur J Med Chem; 2017 Mar; 129():72-109. PubMed ID: 28219048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
